Collaboration. Acceleration. Results.      1 877 TO FIX MS
Myelin Repair Foundation Home Page Donate to Myelin Repair Foundation

Press Releases

Myelin Repair Foundation Announces Long-Term European Partnership with Hertie Foundation (August 11, 2014)
Bionure Inc.’s MS Drug Candidate Shows Positive Results for Myelin Repair in Cell Culture Assay (May 27, 2014)
The Myelin Repair Foundation and NIH Enter Agreement for the Clinical Development of MRF-008, a Drug Repurposing Opportunity for Multiple Sclerosis (January 27, 2014)
Dr. Ted Yednock Joins Myelin Repair Foundation’s Drug Discovery Advisory Board (December 5, 2013)
The Myelin Repair Foundation Enters First International Partnership with Bionure, Inc. (October 31, 2013)
Scott Johnson to Receive BayBio Award at 10th Annual Pantheon Ceremony (October 16, 2013)
The Myelin Repair Foundation Partners with Gencia Corporation to Advance Myelin Repair Therapeutics for Multiple Sclerosis (MS) (August 13, 2013)
Myelin Repair Foundation Grants License for Novel Mouse Model to Biogen Idec (July 1, 2013)
The Myelin Repair Foundation Announces Expansion of its Patent Portfolio (April 22, 2013)
The Myelin Repair Foundation Receives $2 Million Gift from Anonymous Trust to Accelerate Myelin Repair Therapeutics for Multiple Sclerosis (March 12, 2013)
Ballenger Trust Selects the Myelin Repair Foundation to Advance Myelin Repair Therapeutic Development for Multiple Sclerosis (December 18, 2012)
The Myelin Repair Foundation to Present at Partnering for Cures 2012 (November 28, 2012)
Nature Biotechnology Study Highlights New Myelin Specific Approach to Treat Multiple Sclerosis (November 19, 2012)
The Myelin Repair Foundation to Present at 11TH Annual BIO Investor Forum (October 5, 2012)
The Myelin Repair Foundation Launches Its Internship Program Examining the Clinical Drug Development Process in Phase 2 and 3 Clinical Trial Failures (August 30, 2012)
The Myelin Repair Foundation Achieves Phase 1 Myelin Repair Clinical Trial (June 14, 2012)
Nature Neuroscience Study Shows Unique Scientific Support for Potential New Myelin Repair Treatment for Multiple Sclerosis (May 20, 2012)
The Myelin Repair Foundation Welcomes University of California, San Francisco’s Dr. Jonah Chan to its Research Consortium (May 8, 2012)
Multiple Sclerosis Expert Dr. Alfred Sandrock from Biogen Idec Joins the Myelin Repair Foundation's Clinical Advisory Board (March 13, 2012)
Myelin Repair Foundation's President Scott Johnson awarded the Research!America Gordon and Llura Gund Leadership Award. (March 12, 2012)
Myelin Repair Foundation Research Fosters a Clinical Trial for Multiple Sclerosis. (March 7, 2012)
The Myelin Repair Foundation and ENDECE Neural Form Collaboration to Develop Myelin Regenerative Compounds for Multiple Sclerosis (MS) Treatment. (February 8, 2012)
Myelin Repair Foundation Launches the New Myelin Repair Foundation Translational Medicine Center. (January 4, 2012)
Research!America Honors Scott Johnson for Advocacy for Medical Research. (October 5, 2011)
Mice stem cells guided into myelinating cells by the trillions. (September 25, 2011)
Conrad N. Hilton Foundation Grants Myelin Repair Foundation $750,000 to advance human cell cultures for myelin repair. (September 20, 2011)
Fast Company Names the Myelin Repair Foundation Among Top 10 Biotechs for Innovation (February 16, 2011)
Gamers Forecast Use of Mobile Devices and Social Networks to Accelerate Medical Research (January 31, 2011)
Myelin Repair Foundation announces 40+ drug candidate repurposing opportunities for myelin repair. (January 10, 2011)
The Ultimate Experiment: Can Gaming Technology Resuscitate Medical Research? (PDF). (September 7, 2010)
Notable Foundations Join Forces to Support Accelerated Drug Development Model(PDF). (March 25, 2010) Slides & transcript from Webinar on “Developing Cures with Less Time & Capital” (March 25, 2010)
New Patient Advocacy Initiative Calls for Accountability in Medical Research, Asks “Where Are The Cures?” (February 16, 2010)
Myelin Repair Foundation Names Mike Gresser, Ph.D. as Chief Scientific Officer. (January 8, 2010)
Myelin Repair Foundation Announces Chemistry Collaboration with Dalton Pharma Services. (October 22, 2008)
Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership. (May 27, 2008)
Myelin Repair Foundation Names Six Senior Pharma Execs to Drug Discovery Advisory Group (DDAG). (February 6, 2008)
Myelin Repair Foundation Appoints Vice President of Drug Discovery. (January 31, 2007)
Scientific American Names Scott Johnson Among Top 50 Worldwide for Innovations in Multiple Sclerosis Research. (November 6, 2006)
Myelin Repair Foundation Receives $1.2 Million Grant from Robert Wood Johnson Foundation to Further Accelerated Scientific Research Model. (September 21, 2005)
Myelin Repair Foundation Raises First $5 Million: Omidyar Network Caps First Round Funding. (July 18, 2005)
Scientists Identify Molecular "Switches" Affecting Myelin Repair in Multiple Sclerosis. (June 14, 2005)

Video Interviews and Talks

Hear Myelin Repair Foundation CEO Scott Johnson talk about how we're accelerating research for myelin repair therapeutic drugs for multiple sclerosis.

Mendel's Pod:
When Drug Discovery Gets Personal

Watch When Drug Discovery Gets Personal

12Gurus 2012:
Where are the Cures?

Media Contact

Karen Dua
Phone: 408-871-2410